The clinical-stage biotechnology company announced an 85% remission rate in evaluable frontline AML patients treated with mipletamig in combination with standard-of-care venetoclax and azacitidine.

Investing.com -- AST SpaceMobile Inc (NASDAQ: ASTS) stock surged 6.3% following the announcement of a strategic partnership ...

Riley analysts see Meta’s recent investment in Scale AI as a bullish signal for Reddit’s future, highlighting the rising value of unique data sources in the artificial intelligence arms race. “We view ...

Biomea Fusion Inc (NASDAQ: BMEA) stock tumbled 27.4% after the clinical-stage diabetes and obesity company announced plans for an underwritten public offering of ...

Scholar Rock Holding Corp (NASDAQ:SRRK) stock surged 16.4% after the company announced positive results from its Phase 2 EMBRAZE trial evaluating apitegromab in combination with tirzepatide for ...

Jean-Didier Allegrucci has been appointed Vice President of AI System on Chip (SoC) Engineering. He will manage the ...

Investing.com - U.S. President Donald Trump has been a "hawk" on Iran but a "dove" on Russia, according to analysts at Piper ...

Holdings to Hold from Buy on Wednesday, citing a slowdown in advance bookings and reduced fares in its Oceania brand amid ...

Canada is on the verge of producing its first-ever liquefied natural gas (LNG) this weekend from the LNG Canada export ...

Argus Research upgraded its intermediate-term rating on Jabil Inc. to Buy from Hold following a better quarterly results and ...

Investing.com -- Citi analysts say the do-it-yourself (DIY) segment continues to show signs of weakness in the second quarter ...

Capital Markets has initiated coverage on the North American diversified financials sector with a bullish stance on select ...